Ron Bentsur insider trades: Nuvectis Pharma (NVCT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ron reports to the SEC
Open-market buys and sales
96 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | NVCT | ↑ Buy | 12,500 | $20.00 | $250K | Direct | Jul 1, 2026 (1d) |
| Nov 5, 2025 | NVCT | ↑ Buy | 5,000 | $5.72 | $29K | Direct | Nov 6, 2025 (1d) |
| Dec 24, 2024 | NVCT | ↑ Buy | 4,500 | $4.65 | $21K | Direct | Dec 26, 2024 (2d) |
| Nov 15, 2024 | NVCT | ↑ Buy | 20,000 | $4.92 | $98K | Direct | Nov 18, 2024 (3d) |
| May 14, 2024 | NVCT | ↑ Buy | 1,940 | $6.74 | $13K | Direct | May 15, 2024 (1d) |
| May 10, 2024 | NVCT | ↑ Buy | 2,000 | $6.40 | $13K | Direct | May 13, 2024 (3d) |
| Mar 18, 2024 | NVCT | ↑ Buy | 5,000 | $10.29 | $51K | Direct | Mar 19, 2024 (1d) |
| Oct 10, 2023 | NVCT | ↑ Buy | 640 | $11.08 | $7K | Direct | Oct 12, 2023 (2d) |
| Oct 9, 2023 | NVCT | ↑ Buy | 1,080 | $11.21 | $12K | Direct | Oct 10, 2023 (1d) |
| Oct 5, 2023 | NVCT | ↑ Buy | 3,220 | $11.01 | $35K | Direct | Oct 6, 2023 (1d) |
| Aug 16, 2023 | NVCT | ↑ Buy | 350 | $14.61 | $5K | Direct | Aug 16, 2023 (0d) |
| Aug 11, 2023 | NVCT | ↑ Buy | 300 | $14.73 | $4K | Direct | Aug 11, 2023 (0d) |
| Jul 21, 2023 | NVCT | ↑ Buy | 335 | $14.92 | $5K | Direct | Jul 24, 2023 (3d) |
| Jul 19, 2023 | NVCT | ↑ Buy | 200 | $14.33 | $3K | Direct | Jul 20, 2023 (1d) |
| Jul 14, 2023 | NVCT | ↑ Buy | 260 | $15.52 | $4K | Direct | Jul 18, 2023 (4d) |
| Jul 6, 2023 | NVCT | ↑ Buy | 320 | $14.88 | $5K | Direct | Jul 7, 2023 (1d) |
| Jun 26, 2023 | NVCT | ↑ Buy | 750 | $16.50 | $12K | Direct | Jun 27, 2023 (1d) |
| Jun 21, 2023 | NVCT | ↑ Buy | 500 | $17.88 | $9K | Direct | Jun 22, 2023 (1d) |
| Jun 8, 2023 | NVCT | ↑ Buy | 350 | $17.45 | $6K | Direct | Jun 8, 2023 (0d) |
| May 31, 2023 | NVCT | ↑ Buy | 330 | $17.28 | $6K | Direct | Jun 1, 2023 (1d) |
| May 24, 2023 | NVCT | ↑ Buy | 200 | $17.49 | $3K | Direct | May 26, 2023 (2d) |
| May 16, 2023 | NVCT | ↑ Buy | 320 | $17.02 | $5K | Direct | May 18, 2023 (2d) |
| Mar 23, 2023 | NVCT | ↑ Buy | 230 | $12.13 | $3K | Direct | Mar 27, 2023 (4d) |
| Mar 21, 2023 | NVCT | ↑ Buy | 480 | $12.08 | $6K | Direct | Mar 23, 2023 (2d) |
| Mar 20, 2023 | XAIR | ↑ Buy | 2,300 | $6.48 | $15K | Direct | Mar 21, 2023 (1d) |
| Mar 15, 2023 | NVCT | ↑ Buy | 2,160 | $10.86 | $23K | Direct | Mar 16, 2023 (1d) |
| Nov 30, 2022 | NVCT | ↑ Buy | 150 | $7.45 | $1K | Direct | Nov 30, 2022 (0d) |
| Nov 29, 2022 | NVCT | ↑ Buy | 450 | $7.41 | $3K | Direct | Nov 29, 2022 (0d) |
| Nov 18, 2022 | NVCT | ↑ Buy | 750 | $7.23 | $5K | Direct | Nov 21, 2022 (3d) |
| Nov 10, 2022 | NVCT | ↑ Buy | 1,000 | $7.07 | $7K | Direct | Nov 16, 2022 (6d) |
| Sep 30, 2022 | NVCT | ↑ Buy | 1,000 | $7.34 | $7K | Direct | Oct 3, 2022 (3d) |
| Sep 26, 2022 | NVCT | ↑ Buy | 1,500 | $7.85 | $12K | Direct | Sep 27, 2022 (1d) |
| Sep 2, 2022 | NVCT | ↑ Buy | 1,700 | $8.29 | $14K | Direct | Sep 6, 2022 (4d) |
| Aug 29, 2022 | NVCT | ↑ Buy | 1,500 | $9.05 | $14K | Direct | Aug 30, 2022 (1d) |
| Aug 19, 2022 | NVCT | ↑ Buy | 19,426 | $8.69 | $169K | Direct | Aug 22, 2022 (3d) |
| Aug 11, 2022 | NVCT | ↑ Buy | 19,669 | $8.40 | $165K | Direct | Aug 16, 2022 (5d) |
| Jun 30, 2022 | XAIR | ↓ Sell | 40,000 | $6.53 | $261K | Direct | Jul 5, 2022 (5d) |
| Jun 29, 2022 | NVCT | ↑ Buy | 4,000 | $11.63 | $47K | Direct | Jun 30, 2022 (1d) |
| Jun 24, 2022 | NVCT | ↑ Buy | 700 | $12.09 | $8K | Direct | Jun 27, 2022 (3d) |
| May 27, 2022 | NVCT | ↑ Buy | 1,000 | $15.82 | $16K | Direct | May 31, 2022 (4d) |
| May 20, 2022 | NVCT | ↑ Buy | 1,200 | $16.73 | $20K | Direct | May 23, 2022 (3d) |
| May 18, 2022 | NVCT | ↑ Buy | 2,010 | $19.48 | $39K | Direct | May 19, 2022 (1d) |
| May 16, 2022 | NVCT | ↑ Buy | 1,700 | $18.82 | $32K | Direct | May 17, 2022 (1d) |
| May 12, 2022 | NVCT | ↑ Buy | 12,245 | $16.99 | $208K | Direct | May 13, 2022 (1d) |
| Mar 28, 2022 | NVCT | ↑ Buy | 4,000 | $7.05 | $28K | Direct | Mar 29, 2022 (1d) |
| Mar 17, 2022 | NVCT | ↑ Buy | 7,000 | $7.63 | $53K | Direct | Mar 18, 2022 (1d) |
| Feb 14, 2022 | NVCT | ↑ Buy | 8,000 | $5.88 | $47K | Direct | Feb 15, 2022 (1d) |
| Feb 10, 2022 | NVCT | ↑ Buy | 8,500 | $6.34 | $54K | Direct | Feb 11, 2022 (1d) |
| Feb 7, 2022 | NVCT | ↑ Buy | 232,500 | $4.96 | $1.2M | Direct | Feb 8, 2022 (1d) |
| Nov 24, 2021 | XAIR | ↓ Sell | 37,464 | $13.53 | $507K | Direct | Nov 26, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NVCT insiders
Open-market trades in the last 12 months
About Ron Bentsur's insider trades
Ron Bentsur is Chairman & CEO at Nuvectis Pharma (NVCT). Since Mar 29, 2006, Ron has reported 55 open-market purchases worth $3.0M and 41 sales worth $13.6M on SEC Form 4. In the last 12 months: 1 buy ($250K).
15 sales (4% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (26 filings), option exercises (5 filings), shares returned to the company (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.